ArticleCancer management and research2019

Complete response associated with immune checkpoint inhibitors in advanced non-small-cell lung cancer: a meta-analysis of nine randomized controlled trials.

Jie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.